PASG

Passage Bio, Inc. - Common Stock (PASG)

About Passage Bio, Inc. - Common Stock (PASG)

Passage Bio, Inc. operates as a genetic medicines company. It focuses on development of therapies for central nervous system disorders. The company was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.

Details

Daily high

$4.83

Daily low

$4.66

Price at open

$4.76

52 Week High

$20.00

52 Week Low

$3.29

Market cap

15.3M

Dividend yield

Volume

117,622

Avg. volume

24,554

P/E ratio

-.42

Passage Bio, Inc. - Common Stock News